Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Basket Study of Pyrotinib Maleate Tablets in HER2 Mutated or Amplified of Metastatic Solid Tumors

NCT05274191 is registered in ClinicalTrials.gov with Zhongshan Hospital Xiamen University as lead sponsor.

NCT NCT05274191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05274191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Basket Study of Pyrotinib Maleate Tablets in HER2 Mutated or Amplified of Metastatic Solid Tumors
Lead sponsor
Zhongshan Hospital Xiamen University
Phase
Phase 2
Overall status
Unknown status
Start date
March 4, 2022
Completion date
March 15, 2024
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor